Cover Image

The impact of SLCO1B1 genetic polymorphisms on neonatal hyperbilirubinemia: a systematic review with meta-analysis

Show other versions (1)

Objective: To determine whether three variants (388 G>A, 521 T>C, and 463 C>A) of the solute carrier organic anion transporter family member 1B1 (SLCO1B1) are associated with neonatal hyperbilirubinemia. Data source: The China National Knowledge Infrastructure and MEDLINE databases were sea...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiebo Liu (Author), Jun Long (Author), Shaofang Zhang (Author), Xiaoyan Fang (Author), Yuyuan Luo (Author)
Format:	Book
Published:	Brazilian Society of Pediatrics, 2013-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of SLCO1B1 genetic polymorphisms on neonatal hyperbilirubinemia: a systematic review with meta-analysis
by: Jiebo Liu, et al.
Published: (2013)

Impacto dos polimorfismos genéticos SLCO1B1 sobre a hiperbilirrubinemia neonatal: revisão sistemática com metanálise
by: Jiebo Liu, et al.
Published: (2013)

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
by: Chalirmporn Atasilp, et al.
Published: (2022)

Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population
by: Juan Fan, et al.
Published: (2024)

SLCO1B1 c.388A > G variant incidence and the severity of hyperbilirubinemia in Indonesian neonates
by: Radhian Amandito, et al.
Published: (2019)

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
by: Chalitpon Na nakorn, et al.
Published: (2020)

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population
by: Tamara Božina, et al.
Published: (2022)

SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
by: Rattanacheeworn P, et al.
Published: (2020)

Association between SLCO1B3 gene polymorphism and prostate cancer risk: A meta-analytic study
by: Qunshan Shen, et al.
Published: (2018)

Polymorphisms of SLCO1B1 Gene in Sundanese Ethnic Population of Tuberculosis Patients in Indonesia
by: Prayudi Santoso, et al.
Published: (2022)

Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia
by: Jonathan B. Wagner, et al.
Published: (2020)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
by: Sofía Calleja, et al.
Published: (2023)

The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia
by: Sychev DA, et al.
Published: (2016)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
by: Zachary L. Taylor, et al.
Published: (2021)

Effect of SLCO1B1 Polymorphisms on High‐Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma
by: Rachael R. Schulte, et al.
Published: (2021)

Evaluation of the effect of the carrier of polymorphic variants of the SLCO1B1 gene on efficacy and safety in patients during treatment with statins
by: N. A. Rumyantsev, et al.
Published: (2018)

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?
by: Kim CO, et al.
Published: (2017)

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
by: Kohei Ninomiya, et al.
Published: (2022)

Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia
by: Hui Yang, et al.
Published: (2016)

The role of UGT1A1 (c.-3279 T > G) gene polymorphisms in neonatal hyperbilirubinemia susceptibility
by: Zijin Li, et al.
Published: (2020)

Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
by: Aleksey V. Shchulkin, et al.
Published: (2023)

EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY
by: A. V. Semenov, et al.
Published: (2016)

Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population
by: Filipp Filippovich Vasilyev, et al.
Published: (2016)

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
by: Thakkar D, et al.
Published: (2017)

Association between KIF1B rs17401966 genetic polymorphism and hepatocellular carcinoma susceptibility: an updated meta-analysis
by: Ying-ying Luo, et al.
Published: (2019)

Rapid Detection of SLCO1B1 Polymorphisms Using Duplex Fluorescence Melting Curve Analysis: Implications for Personalized Drug Dosing in Clinical Settings
by: Yu Z, et al.
Published: (2024)

Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
by: Shu Q, et al.
Published: (2021)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
by: Li Q, et al.
Published: (2019)

Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury
by: Mohammad Alshabeeb, et al.
Published: (2022)

Clinical case of statin-induced myopathy in female patient with compensated hypothyroidism and unfavorable polymorphic variant of SLCO1B1*5 (c.521T>C)
by: Liya A. Lugovaya, et al.
Published: (2021)

Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver
by: Bianca D. vanGroen, et al.
Published: (2020)

Developing and evaluating a predictive model for neonatal hyperbilirubinemia based on UGT1A1 gene polymorphism and clinical risk factors
by: Zhaoyang Cui, et al.
Published: (2024)

Effect of Fenofibrate on Neonatal Hyperbilirubinemia: A Systematic Review and Meta-analysis
by: Nasrin Zamiri-Miandoab, et al.
Published: (2021)

<i>CYP3A5*3</i> and <i>SLCO1B1</i> c.521T>C Polymorphisms Influence the Pharmacokinetics of Atorvastatin and 2-Hydroxy Atorvastatin
by: Jin-Woo Park, et al.
Published: (2022)

Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
by: Sychev DA, et al.
Published: (2017)

SLCO1B1 *15 allele is associated with methotrexate‐induced nausea in pediatric patients with inflammatory bowel disease
by: Rishi S. Mehta, et al.
Published: (2022)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015)

211 G to A variation of UGT1A1 and severe neonatal hyperbilirubinemia
by: Yu-Jung Lin, et al.
Published: (2018)

<it>SLCO1B1 </it>rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group
by: Krieger José E, et al.
Published: (2011)